Clinical benefits of probiotic canine-derived Bifidobacterium animalis strain AHC7 in dogs with acute idiopathic diarrhea

R. L. Kelley; Debbie Minikhiem; Barry Kiely; Liam O'Mahony; David O'Sullivan; Tom Boileau; Jean Soon Park

Clinical benefits of probiotic canine-derived Bifidobacterium animalis strain AHC7 in dogs with acute idiopathic diarrhea

R. L. Kelley
, Debbie Minikhiem
, Barry Kiely
, Liam O'Mahony
, David O'Sullivan
, Tom Boileau
, Jean Soon Park

Research output: Contribution to journal › Article › peer-review

Abstract

This study evaluated the effect of supplementation with canine-derived probiotic Bifidobacterium animalis strain AHC7 (Iams Prostora, Procter & Gamble Pet Care) on the resolution rate of acute idiopathic diarrhea in dogs randomly assigned to receive a placebo (n = 18) or the probiotic (n = 13). Nutritional management with the probiotic fed at 2 × 10¹⁰ CFU/day significantly reduced the time to resolution (3.9 ± 2.3 versus 6.6 ± 2.7 days; P <.01) and reduced the percentage of dogs that were administered metronidazole (38.5% versus 50.0%) compared with placebo. Probiotic B. animalis AHC7 may provide veterinarians another tool for management of acute diarrhea in dogs.

Original language	English
Pages (from-to)	121-130
Number of pages	10
Journal	Veterinary Therapeutics
Volume	10
Issue number	3
Publication status	Published - 2009
Externally published	Yes

Cite this

@article{7171087506ee43219b46b5de313c8257,

title = "Clinical benefits of probiotic canine-derived Bifidobacterium animalis strain AHC7 in dogs with acute idiopathic diarrhea",

abstract = "This study evaluated the effect of supplementation with canine-derived probiotic Bifidobacterium animalis strain AHC7 (Iams Prostora, Procter \& Gamble Pet Care) on the resolution rate of acute idiopathic diarrhea in dogs randomly assigned to receive a placebo (n = 18) or the probiotic (n = 13). Nutritional management with the probiotic fed at 2 × 1010 CFU/day significantly reduced the time to resolution (3.9 ± 2.3 versus 6.6 ± 2.7 days; P <.01) and reduced the percentage of dogs that were administered metronidazole (38.5\% versus 50.0\%) compared with placebo. Probiotic B. animalis AHC7 may provide veterinarians another tool for management of acute diarrhea in dogs.",

author = "Kelley, \{R. L.\} and Debbie Minikhiem and Barry Kiely and Liam O'Mahony and David O'Sullivan and Tom Boileau and Park, \{Jean Soon\}",

year = "2009",

language = "English",

volume = "10",

pages = "121--130",

journal = "Veterinary Therapeutics",

issn = "1528-3593",

publisher = "Veterinary Learning Systems",

number = "3",

}

TY - JOUR

T1 - Clinical benefits of probiotic canine-derived Bifidobacterium animalis strain AHC7 in dogs with acute idiopathic diarrhea

AU - Kelley, R. L.

AU - Minikhiem, Debbie

AU - Kiely, Barry

AU - O'Mahony, Liam

AU - O'Sullivan, David

AU - Boileau, Tom

AU - Park, Jean Soon

PY - 2009

Y1 - 2009

N2 - This study evaluated the effect of supplementation with canine-derived probiotic Bifidobacterium animalis strain AHC7 (Iams Prostora, Procter & Gamble Pet Care) on the resolution rate of acute idiopathic diarrhea in dogs randomly assigned to receive a placebo (n = 18) or the probiotic (n = 13). Nutritional management with the probiotic fed at 2 × 1010 CFU/day significantly reduced the time to resolution (3.9 ± 2.3 versus 6.6 ± 2.7 days; P <.01) and reduced the percentage of dogs that were administered metronidazole (38.5% versus 50.0%) compared with placebo. Probiotic B. animalis AHC7 may provide veterinarians another tool for management of acute diarrhea in dogs.

AB - This study evaluated the effect of supplementation with canine-derived probiotic Bifidobacterium animalis strain AHC7 (Iams Prostora, Procter & Gamble Pet Care) on the resolution rate of acute idiopathic diarrhea in dogs randomly assigned to receive a placebo (n = 18) or the probiotic (n = 13). Nutritional management with the probiotic fed at 2 × 1010 CFU/day significantly reduced the time to resolution (3.9 ± 2.3 versus 6.6 ± 2.7 days; P <.01) and reduced the percentage of dogs that were administered metronidazole (38.5% versus 50.0%) compared with placebo. Probiotic B. animalis AHC7 may provide veterinarians another tool for management of acute diarrhea in dogs.

UR - https://www.scopus.com/pages/publications/74949095958

M3 - Article

C2 - 20037966

AN - SCOPUS:74949095958

SN - 1528-3593

VL - 10

SP - 121

EP - 130

JO - Veterinary Therapeutics

JF - Veterinary Therapeutics

IS - 3

ER -

Clinical benefits of probiotic canine-derived Bifidobacterium animalis strain AHC7 in dogs with acute idiopathic diarrhea

Abstract

Other files and links

Fingerprint

Cite this